Hepatic adenylate energy charge levels in patients with hepatoma after hepatic artery embolization

被引:0
|
作者
Li, L
Yan, LN
Chen, XL
Lu, WS
Xie, XD
Wu, YT
机构
[1] W China Univ Med Sci, Dept Gen Surg, Affiliated Hosp 1, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] W China Univ Med Sci, Dept Radiol, Affiliated Hosp 1, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To evaluate hepatic energy charge levels of the patients with hepatoma after hepatic artery embolization and its relation to postoperative complications. METHODS Sixty-nine patients with hepatoma were continuously measured for their arterial blood ketone body ratio (AKBR) and compared with their postoperative clinical course or conventional liver function test after various hepatic artery embolization. RESULTS AKBR in high radiation dose or jaundice group drastically decreased at 1 - 3 days and recovered slowly. Patients were classified into three groups according to the value of AKBR: group A (35 cases), AKBR remained higher than 0.7; group B (31 cases), AKBR had transiently dropped to 0.4-0.7 and then increased to preoperative value; and group C (3 cases), AKBR decreased steadily to below 0.4, The occurrence rate of various complications were 5.7%, 32.3% and 100% in the three groups, respectively (P<0.005). CONCLUSION The AKBR which reflects hepatic mitochondria redox state is more reliable as a direct indicator to assess hepatic tolerance for embolization than routine liver function test.
引用
收藏
页码:109 / 111
页数:3
相关论文
共 50 条
  • [41] Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection
    Hsieh, CB
    Yu, CY
    Tzao, C
    Chu, HC
    Chen, TW
    Hsieh, HF
    Liu, YC
    Yu, JC
    EJSO, 2006, 32 (01): : 72 - 76
  • [42] Comparison of post-embolization syndrome after hepatic artery embolization in liver cirrhotic patients versus non-cirrhotic patients
    Abu Rmilah, A.
    Chad, F.
    Nyberg, S.
    Andrews, J.
    TRANSPLANTATION, 2019, 103 (08) : 331 - 331
  • [43] POTENTIALITIES OF PREOPERATIVE HEPATIC-ARTERY EMBOLIZATION IN PATIENTS WITH LIVER NEOPLASMS
    GRANOV, AM
    TARAZOV, PG
    VOPROSY ONKOLOGII, 1990, 36 (10) : 1189 - &
  • [44] SYMPTOM CLUSTERS IN HEPATOCELLULAR CARCINOMA PATIENTS WITH TRANSCATHETER HEPATIC ARTERY EMBOLIZATION
    Lin, Tsui Hua
    Hsu, Hsin Tien
    Lin, Yu-Hua
    Chen, Tai Bin
    Sen Chen, Yao
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E90 - E90
  • [45] Endovascular embolization of a giant hepatic artery aneurysm
    Wang, Judy
    Qi, Sara
    Cabalag, Carlos
    Chuen, Jason
    ANZ JOURNAL OF SURGERY, 2019, 89 (12) : 1666 - 1668
  • [46] EMBOLIZATION OF THE HEPATIC-ARTERY FOR HEMANGIOMA OF THE LIVER
    TARAZOV, PG
    POLYSALOV, VN
    RYZHKOV, VK
    VOPROSY ONKOLOGII, 1990, 36 (05) : 583 - 587
  • [47] Technique of hepatic artery embolization in metastasing carcinoids
    Winkelbauer, FW
    Niederle, B
    Lammer, J
    CHIRURGISCHE GASTROENTEROLOGIE, 1997, 13 (04): : 286 - 291
  • [48] Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: A commentary
    Norton, JA
    Kerlan, RK
    CANCER JOURNAL, 2003, 9 (04): : 241 - 243
  • [49] Resection of a locally advanced hilar tumor and the hepatic artery after stepwise hepatic arterial embolization: A case report
    Miura, Takuya
    Hakamada, Kenichi
    Ohata, Takashi
    Narumi, Shunji
    Toyoki, Yoshikazu
    Nara, Masaki
    Ishido, Keinosuke
    Ohashi, Motonari
    Akasaka, Harue
    Jin, Hiroyuki
    Kubo, Norihito
    Ono, Shuichi
    Kijima, Hiroshi
    Sasaki, Mutsuo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (22) : 3587 - 3590
  • [50] Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model
    Ueshima, Eisuke
    Nishiofuku, Hideyuki
    Takaki, Haruyuki
    Hirata, Yutaka
    Kodama, Hiroshi
    Tanaka, Toshihiro
    Kichikawa, Kimihiko
    Yamakado, Koichiro
    Okada, Takuya
    Sofue, Keitaro
    Yamaguchi, Masato
    Sugimoto, Koji
    Murakami, Takamichi
    LIVER CANCER, 2020, 9 (01) : 63 - 72